Cargando…

Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review

The global prevalence of leprosy has decreased substantially, and cases of leprosy infection are extremely rare in China. In this report, we present a case of recurrent choriocarcinoma complicated by leprosy infection during chemotherapy. PATIENT CONCERNS: A 24-year-old Chinese woman (gravida 3, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shiqi, Lin, Xiaojuan, Yin, Rutie, Wang, Wei, Li, Qingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419345/
https://www.ncbi.nlm.nih.gov/pubmed/37565881
http://dx.doi.org/10.1097/MD.0000000000034548
_version_ 1785088495139684352
author Hu, Shiqi
Lin, Xiaojuan
Yin, Rutie
Wang, Wei
Li, Qingli
author_facet Hu, Shiqi
Lin, Xiaojuan
Yin, Rutie
Wang, Wei
Li, Qingli
author_sort Hu, Shiqi
collection PubMed
description The global prevalence of leprosy has decreased substantially, and cases of leprosy infection are extremely rare in China. In this report, we present a case of recurrent choriocarcinoma complicated by leprosy infection during chemotherapy. PATIENT CONCERNS: A 24-year-old Chinese woman (gravida 3, para 2) presented to a local hospital with vaginal bleeding. Her medical history included a previous diagnosis of hydatidiform mole. DIAGNOSES, INTERVENTIONS AND OUTCOMES: The patient was diagnosed with choriocarcinoma and received chemotherapy in 6 cycles. Shortly after the initial treatment was completed, the disease recurred twice with resistance to multiple chemotherapeutic agents. In her second recurrence of choriocarcinoma, she was diagnosed with leprosy with many cutaneous nodules throughout her entire body. The patient was administered chemical treatment for leprosy with the multidrug therapy regimen after being diagnosed. To prevent exacerbating the infection, no immunotherapy was utilized to treat cancer, and the infection was well-controlled at the conclusion of anticancer therapy. LESSONS: Because of immunological reduction, cancer patients are susceptible to a variety of infections. For patients with cancer, prevention and early detection of rare infectious diseases should receive special attention. Immunotherapy must be used with caution when treating patients with cancer and infections.
format Online
Article
Text
id pubmed-10419345
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104193452023-08-12 Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review Hu, Shiqi Lin, Xiaojuan Yin, Rutie Wang, Wei Li, Qingli Medicine (Baltimore) 5600 The global prevalence of leprosy has decreased substantially, and cases of leprosy infection are extremely rare in China. In this report, we present a case of recurrent choriocarcinoma complicated by leprosy infection during chemotherapy. PATIENT CONCERNS: A 24-year-old Chinese woman (gravida 3, para 2) presented to a local hospital with vaginal bleeding. Her medical history included a previous diagnosis of hydatidiform mole. DIAGNOSES, INTERVENTIONS AND OUTCOMES: The patient was diagnosed with choriocarcinoma and received chemotherapy in 6 cycles. Shortly after the initial treatment was completed, the disease recurred twice with resistance to multiple chemotherapeutic agents. In her second recurrence of choriocarcinoma, she was diagnosed with leprosy with many cutaneous nodules throughout her entire body. The patient was administered chemical treatment for leprosy with the multidrug therapy regimen after being diagnosed. To prevent exacerbating the infection, no immunotherapy was utilized to treat cancer, and the infection was well-controlled at the conclusion of anticancer therapy. LESSONS: Because of immunological reduction, cancer patients are susceptible to a variety of infections. For patients with cancer, prevention and early detection of rare infectious diseases should receive special attention. Immunotherapy must be used with caution when treating patients with cancer and infections. Lippincott Williams & Wilkins 2023-08-11 /pmc/articles/PMC10419345/ /pubmed/37565881 http://dx.doi.org/10.1097/MD.0000000000034548 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 5600
Hu, Shiqi
Lin, Xiaojuan
Yin, Rutie
Wang, Wei
Li, Qingli
Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title_full Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title_fullStr Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title_full_unstemmed Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title_short Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
title_sort recurrent choriocarcinoma complicated with leprosy during chemotherapy: a case report and literature review
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419345/
https://www.ncbi.nlm.nih.gov/pubmed/37565881
http://dx.doi.org/10.1097/MD.0000000000034548
work_keys_str_mv AT hushiqi recurrentchoriocarcinomacomplicatedwithleprosyduringchemotherapyacasereportandliteraturereview
AT linxiaojuan recurrentchoriocarcinomacomplicatedwithleprosyduringchemotherapyacasereportandliteraturereview
AT yinrutie recurrentchoriocarcinomacomplicatedwithleprosyduringchemotherapyacasereportandliteraturereview
AT wangwei recurrentchoriocarcinomacomplicatedwithleprosyduringchemotherapyacasereportandliteraturereview
AT liqingli recurrentchoriocarcinomacomplicatedwithleprosyduringchemotherapyacasereportandliteraturereview